Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Vaxcyte, Inc. (PCVX) had Non-Operating Income/Expense of $29.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-212.83M |
|
-- |
|
-- |
|
$242.38M |
|
$-242.38M |
|
|
Non-Operating Income/Expense |
$29.55M |
$-212.83M |
|
$-212.83M |
|
$-212.83M |
|
$-212.83M |
|
$-212.83M |
|
$-212.83M |
|
$-242.38M |
|
$-239.45M |
|
136.20M |
|
136.20M |
|
$-1.56 |
|
$-1.56 |
|
| Balance Sheet Financials | |
$1.77B |
|
$253.49M |
|
$1.40B |
|
$3.17B |
|
$200.05M |
|
-- |
|
$78.67M |
|
$278.72M |
|
$2.89B |
|
$2.89B |
|
$2.89B |
|
130.03M |
|
| Cash Flow Statement Financials | |
$-430.75M |
|
$322.23M |
|
$-0.39M |
|
$389.19M |
|
$282.55M |
|
$-106.65M |
|
$102.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-441.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.36% |
|
-7.36% |
|
-6.71% |
|
-7.36% |
|
$22.25 |
|
$-3.24 |
|
$-3.16 |
|